COVID-19 PREPAREDNESS     RESOURCES
ANNOUNCEMENT  

Ivenix Infusion System earns FDA clearance.

  LEARN MORE

Investors

We are honored to have visionary investors backing our development of the Ivenix Infusion System. Each shares our conviction to advance the IV infusion pump market. Their innovative thinking and affinity for smart design helps guide our dedication to developing the most advanced infusion management system available. Together, we are committed to helping care facilities optimize workflows, reduce costs, and improve patient safety.

Current Investors

Current Investors include Cardinal Partners, CICA, Inc., Easterly Capital, F-Prime (formerly Fidelity Biosciences), SCP Vitalife Partners, and WuXi Healthcare Ventures.

For More Information